Gram negative septic shock. Experimental and clinical studies.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000667:Ampicillin / Q000627:therapeutic use; D000818:Animals; D001163:Arteriovenous Anastomosis; D001794:Blood Pressure; D002199:Capillary Permeability; D002302:Cardiac Output; D002512:Cephalothin / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D004285:Dogs; D004926:Escherichia coli / Q000302:isolation & purification; D004927:Escherichia coli Infections; D005260:Female; D006439:Hemodynamics; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D007709:Klebsiella / Q000302:isolation & purification; D007710:Klebsiella Infections; D008297:Male; D008775:Methylprednisolone; D008875:Middle Aged; D010406:Penicillins / Q000627:therapeutic use; D011113:Polymyxins / Q000627:therapeutic use; D011549:Pseudomonas / Q000302:isolation & purification; D011552:Pseudomonas Infections; D012772:Shock, Septic / Q000097:blood / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D013752:Tetracycline / Q000627:therapeutic use; D014690:Venous Pressure
D010406:Penicillins; D011113:Polymyxins; D007612:Kanamycin; D002701:Chloramphenicol; D000667:Ampicillin; D013752:Tetracycline; D002512:Cephalothin; D008775:Methylprednisolone